- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2024
- Keyword
-
Krebs
Therapie
Immuntherapie
- Event
-
Veröffentlichung
- (where)
-
Düsseldorf
- (who)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (when)
-
2024
- Creator
- Contributor
-
Hanenberg, Helmut
Kassack, Matthias
- URN
-
urn:nbn:de:hbz:061-20240603-111159-4
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bister, Arthur
- Hanenberg, Helmut
- Kassack, Matthias
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Time of origin
- 2024
Other Objects (12)
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Chimeric antigen receptor-redirected regulatory T cells as a therapy for multiple sclerosis and other neurological diseases
Investigations on polysialic acid as a potential tumor-specific target for chimeric antigen receptor T cell therapy
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies
Tumor-specific reactive oxygen species accelerators for improved chimeric antigen receptor (CAR) T cell therapy in B cell malignancies
Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Chimeric antigen receptor-redirected regulatory T cells as a therapy for multiple sclerosis and other neurological diseases
Investigations on polysialic acid as a potential tumor-specific target for chimeric antigen receptor T cell therapy
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies
Tumor-specific reactive oxygen species accelerators for improved chimeric antigen receptor (CAR) T cell therapy in B cell malignancies
Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Chimeric antigen receptor-redirected regulatory T cells as a therapy for multiple sclerosis and other neurological diseases
Investigations on polysialic acid as a potential tumor-specific target for chimeric antigen receptor T cell therapy
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies
Tumor-specific reactive oxygen species accelerators for improved chimeric antigen receptor (CAR) T cell therapy in B cell malignancies